Project CHRYSANTHEMUM

Project: CHRYSANTHEMUM is a SPARTAN-III bioaugmentation procedures, similar to those of the SPARTAN-II's. With advances in technology, however, the survival rate for SPARAN-III candidates was usually 100%, as opposed to the 44% survival rate of the SPARTAn-IIs.